Immuron Limited American Depositary Shares
IMRN Real Time Price USDRecent trades of IMRN by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by IMRN's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
No Corporate Lobbying instances for this ticker
Corporate Lobbying DashboardEstimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Methods and compositions for the treatment and/or prophylaxis of Dec. 04, 2018
-
Patent Title: Anti-lps enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder Nov. 06, 2018
-
Patent Title: Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder Apr. 17, 2018
-
Patent Title: Composition and method for the treatment and prevention of enteric bacterial infections Aug. 02, 2016
-
Patent Title: Composition and method for the treatment and prevention of enteric bacterial infections Jan. 28, 2014
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of IMRN in WallStreetBets Daily Discussion
Recent insights relating to IMRN
Recent picks made for IMRN stock on CNBC
ETFs with the largest estimated holdings in IMRN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IMRN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.